We can readily understand why investors are attracted to unprofitable companies. By way of example, Microbot Medical (NASDAQ:MBOT) has seen its share price rise 142% over the last year, delighting ...

Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...

Fintel reports that on November 28, 2025, HC Wainwright & Co. reiterated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 434.50% Upside As of ...

KUALA LUMPUR: Over 100,000 technologists and technicians including those specialising in emerging technologies are currently registered under the Malaysia Board of Technologists (MBOT), says Chang Lih ...

Microbot Medical Inc. (MBOT) has been beaten down lately with too much selling pressure. While the stock has lost 28.2% over the past four weeks, there is light at the end of the tunnel as it is now ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Microbot Medical ( (MBOT)) just unveiled ...

MBOT’s main value driver is its LIBERTY robot. This is a disposable, portable endovascular robot that has great potential. LIBERTY showed strong ACCESS-PVI data and now awaits FDA 510(k) clearance for ...

An exclusive, behind-the-scenes look at the quest to rid the Everglades of invasive Burmese pythons—including a record-breaking, 215-pound giant. Researchers Ian Bartoszek (left), Ian Easterling, and ...

We recently published a list of the 10 Best Rising Penny Stocks to Buy According to Analysts. In this article, we are going to take a look at where Microbot Medical Inc. (NASDAQ:MBOT) stands against ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Shares of Microbot Medical (NASDAQ:MBOT) rose in the premarket on Wednesday after the MedTech firm announced that a pivotal trial for its Liberty endovascular surgical robotic system reached the ...